The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,419,829 in first-year total cost, median $983,042.
Most frequent study sections
- Special Emphasis Panel[ZRG1 NV-C (10)]2
- Special Emphasis Panel[ZNS1 SRB-A (11)]1
Most frequent institutions
- ALCAMENA STEM CELL THERAPEUTICS, LLC1
- COOLTECH LLC1
- MAGNETIC TIDES, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain1R44NS145934-01 | NESTI, EDMUND | ALCAMENA STEM CELL THERAPEUTICS, LLC, MD | $1,500,000 | ZNS1 |
| 2025 | Development of Mi-Helper: A Thermodynamic Neuromodulation Device for Migraine Relief1R44NS143568-01 | SCHAEFER, STEVEN EDWARDTEPPER, STEWART | COOLTECH LLC, MD | $983,042 | ZRG1 |
| 2025 | A novel method of non-invasive brain stimulation to enhance motor function in chronic stroke patients1R44NS139730-01A1 | LABRUNA, LUDOVICA | MAGNETIC TIDES, INC., CA | $936,787 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.